INOVOBIOLOGIC, INC. Patent applications |
Patent application number | Title | Published |
20150086621 | DIETARY FIBER COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISEASE - Dietary fibre compositions composed of 48-90% w/w glucomannan, 5-20% w/w xanthan gum and 5-30% w/w alginate in combination with metformin, sitagliptin or a mixture thereof for the treatment of metabolic disease are disclosed. | 03-26-2015 |
20140120239 | DIETARY SUPPLEMENT AND METHODS OF USE - One aspect of the invention provides dietary fiber compositions comprising effective amounts of glucomannan, xanthan gum, and alginate to produce a desired viscosity. The invention also provides food products comprising an effective amount of a dietary fiber composition. In other aspects, the invention provides methods for preparing a dietary fiber composition or a food product comprising a dietary fiber composition and methods for promoting satiety, promoting weight loss, lowering blood glucose levels, or lowering blood cholesterol levels in a mammal. | 05-01-2014 |
20120040049 | DIETARY SUPPLEMENT, AND METHODS OF USE - One aspect of the invention provides dietary fiber compositions comprising effective amounts of glucomannan, xanthan gum, and alginate to produce a desired viscosity. The invention also provides food products comprising an effective amount of a dietary fiber composition. In other aspects, the invention provides methods for preparing a dietary fiber composition or a food product comprising a dietary fiber composition, and methods for promoting satiety, promoting weight loss, lowering blood glucose levels, or lowering blood cholesterol levels in a mammal | 02-16-2012 |
20110223192 | METHODS FOR DELAYING THE ONSET AND/OR REDUCING THE SEVERITY OF METABOLIC SYNDROME - The present invention provides dietary supplements, medical foods, and methods effective to delay the onset, slow the progression, and/or ameliorate at least one of the symptoms of a metabolic disease or disorder, such as metabolic syndrome, type I diabetes, type II diabetes, pancreatic disease, and/or hyperlipidemia. | 09-15-2011 |